Reference | Year | Journal | Country | Sample Size | Design | Lymphoscintigraphy | Mean Length of Follow-up |
---|---|---|---|---|---|---|---|
Schrenk P et al.(1) | 2000 | Cancer | Austria | 35 | Prospective | Used | 15.4 M |
Roumen RM et al.(2) | 2001 | Br J Surg | Netherlands | 100 | Prospective | Used | 24 M |
Burak WE et al.(3) | 2002 | Am J Surg | USA | 48 | Prospective | Not Used | 15.4 M |
Haid A et al.(4) | 2002 | Breast Ca Res T | Austria | 57 | Retrospective | Used | 18 M |
Temple LK et al.(5) | 2002 | Ann Surg Oncol | USA | 171 | Prospective | Used | 3 M, 6 M, 12 M |
Swenson KK et al.(6) | 2002 | Ann Surg Oncol | USA | 169 | Prospective | Not Used | 1 M, 6 M, 12 M |
Haid A et al.(7) | 2002 | Eur J Surg Ocol | Austria | 66 | Prospective | Used | Not specified |
Leidenius M et al.(8) | 2003 | Am J Surg | Finland | 49 | Prospective | Used | 2 W |
Schijven MP et al.(9) | 2003 | Eur J Surg Oncol | Netherlands | 180 | Retrospective | Used | 12 M |
Blanchard DK et al.(10) | 2003 | Arch Surg | USA | 685 | Prospective | Used | 2.4 Y |
Veronesi U et al.(11) | 2003 | N Engl J Med | Italy | 100 | Prospective | Used | 6 M, 24 M |
Rietman JS et al.(12) | 2003 | Cancer | Netherlands | 66 | Prospective | Used* | 6 W |
Peintinger F et al.(13) | 2003 | Br J Cancer | Austria | 25 | Prospective | Used | 1 W, 9–12 M |
Baron RH et al.(14) | 2004 | Oncol Nurs Forum | USA | 197 | Prospective | Used | 24 M |
Armer J et al.(15) | 2004 | Lymphololgy | USA | 9 | Retrospective | Used | 9 M |
Ronka RH et al.(16) | 2004 | Acta Oncol | Finland | 57 | Prospective | Used | 12.6 M |
Rietman JS et al.(17) | 2004 | Ann Surg Oncol | Netherlands | 66 | Prospective | Used* | 12 M |
Langer S et al.(18) | 2004 | Am Surg | USA | 40 | Retrospective | Not Used | 51 M |
Luini A et al.(19) | 2005 | Breast Ca Res T | Italy | 244 | Prospective | Used | 6–12 M |
Ronka RH et al.(20) | 2005 | Breast | Finland | 43 | Prospective | Used | 12 M |